Pharmacokinetic profile of defibrotide in patients with renal impairment.
about
Defibrotide for children and adults with hepatic veno-occlusive disease post hematopoietic cell transplantation.Defibrotide: An Oligonucleotide for Sinusoidal Obstruction Syndrome.Defibrotide sodium for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome.Defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome with multiorgan failure
P2860
Pharmacokinetic profile of defibrotide in patients with renal impairment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacokinetic profile of defibrotide in patients with renal impairment.
@en
Pharmacokinetic profile of defibrotide in patients with renal impairment.
@nl
type
label
Pharmacokinetic profile of defibrotide in patients with renal impairment.
@en
Pharmacokinetic profile of defibrotide in patients with renal impairment.
@nl
prefLabel
Pharmacokinetic profile of defibrotide in patients with renal impairment.
@en
Pharmacokinetic profile of defibrotide in patients with renal impairment.
@nl
P2093
P2860
P356
P1476
Pharmacokinetic profile of defibrotide in patients with renal impairment.
@en
P2093
Elena Tudone
Jean-Francois Marier
Katie Zomorodi
Mark Eller
Paola Tocchetti
Thomas C Marbury
P2860
P304
P356
10.2147/DDDT.S112181
P407
P577
2016-08-16T00:00:00Z